CF
BNTX icon

Centaurus Financial’s BioNTech BNTX Stock Holding History

Centaurus Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,311
Closed -$163K – 762
2023
Q1 		$163K Buy
1,311
+87
+7% +$11.9K 0.01% 718
2022
Q4 		$184K Sell
1,224
-21
-2% -$3.23K 0.02% 630
2022
Q3 		$168K Buy
1,245
+15
+1% +$2.29K 0.02% 664
2022
Q2 		$183K Sell
1,230
-218
-15% -$33.3K 0.02% 648
2022
Q1 		$247K Buy
1,448
+71
+5% +$11.9K 0.02% 599
2021
Q4 		$355K Buy
+1,377
New +$377K 0.03% 532

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centaurus Financial's BNTX Position: Q2 2023 in Review

Centaurus Financial sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 1,311 shares — an estimated $163K sold.

Centaurus Financial first reported a position in BNTX in Q4 2021 and held it in 6 quarters. The position peaked at $355K in Q4 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Centaurus Financial reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Centaurus Financial sold 1,311 BioNTech shares in Q2 2023, an estimated $163K.
  • Centaurus Financial first reported a position in BioNTech in Q4 2021 and held it in 6 quarters.
  • Centaurus Financial's BioNTech position peaked at $355K in Q4 2021.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Centaurus Financial's 13F filing for Q2 2023, filed 15 Aug 2023.